nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CA13—nerve—hypothyroidism	0.0164	0.0341	CbGeAlD
Zonisamide—CA13—tongue—hypothyroidism	0.016	0.0333	CbGeAlD
Zonisamide—Muscle twitching—Liothyronine—hypothyroidism	0.0135	0.0338	CcSEcCtD
Zonisamide—SCN11A—nerve—hypothyroidism	0.0112	0.0233	CbGeAlD
Zonisamide—SCN2B—heart—hypothyroidism	0.00837	0.0174	CbGeAlD
Zonisamide—SCN2B—cardiovascular system—hypothyroidism	0.0079	0.0164	CbGeAlD
Zonisamide—SCN1B—heart—hypothyroidism	0.00757	0.0157	CbGeAlD
Zonisamide—SCN1B—cardiovascular system—hypothyroidism	0.00715	0.0148	CbGeAlD
Zonisamide—CA8—heart—hypothyroidism	0.00712	0.0148	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00702	0.0591	CbGpPWpGaD
Zonisamide—CA8—cardiovascular system—hypothyroidism	0.00672	0.0139	CbGeAlD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00652	0.055	CbGpPWpGaD
Zonisamide—SCN4B—adrenal cortex—hypothyroidism	0.00614	0.0128	CbGeAlD
Zonisamide—CA13—heart—hypothyroidism	0.00609	0.0126	CbGeAlD
Zonisamide—CA10—pituitary gland—hypothyroidism	0.00607	0.0126	CbGeAlD
Zonisamide—SCN2B—thyroid gland—hypothyroidism	0.00603	0.0125	CbGeAlD
Zonisamide—Coma—Dextrothyroxine—hypothyroidism	0.00596	0.0149	CcSEcCtD
Zonisamide—Coma—Levothyroxine—hypothyroidism	0.00596	0.0149	CcSEcCtD
Zonisamide—CA8—pituitary gland—hypothyroidism	0.00595	0.0123	CbGeAlD
Zonisamide—SCN4B—heart—hypothyroidism	0.00594	0.0123	CbGeAlD
Zonisamide—SCN3B—pituitary gland—hypothyroidism	0.00584	0.0121	CbGeAlD
Zonisamide—Hyperkinesia—Levothyroxine—hypothyroidism	0.00569	0.0142	CcSEcCtD
Zonisamide—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00569	0.0142	CcSEcCtD
Zonisamide—SCN1B—adrenal gland—hypothyroidism	0.00565	0.0117	CbGeAlD
Zonisamide—SCN1B—thyroid gland—hypothyroidism	0.00545	0.0113	CbGeAlD
Zonisamide—CA8—adrenal gland—hypothyroidism	0.00531	0.011	CbGeAlD
Zonisamide—CA11—adrenal cortex—hypothyroidism	0.00529	0.011	CbGeAlD
Zonisamide—SCN3B—adrenal gland—hypothyroidism	0.00522	0.0108	CbGeAlD
Zonisamide—CA8—thyroid gland—hypothyroidism	0.00513	0.0106	CbGeAlD
Zonisamide—CA11—heart—hypothyroidism	0.00512	0.0106	CbGeAlD
Zonisamide—SCN3B—thyroid gland—hypothyroidism	0.00503	0.0104	CbGeAlD
Zonisamide—Hypertension—Liothyronine—hypothyroidism	0.00501	0.0125	CcSEcCtD
Zonisamide—SCN4B—pituitary gland—hypothyroidism	0.00497	0.0103	CbGeAlD
Zonisamide—Muscle twitching—Liotrix—hypothyroidism	0.00488	0.0122	CcSEcCtD
Zonisamide—Cardiac failure—Levothyroxine—hypothyroidism	0.00485	0.0121	CcSEcCtD
Zonisamide—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00485	0.0121	CcSEcCtD
Zonisamide—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00485	0.0121	CcSEcCtD
Zonisamide—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00485	0.0121	CcSEcCtD
Zonisamide—CYP2C19—urine—hypothyroidism	0.00483	0.01	CbGeAlD
Zonisamide—SCN2B—cerebellum—hypothyroidism	0.00477	0.00991	CbGeAlD
Zonisamide—CA1—nerve—hypothyroidism	0.00472	0.00979	CbGeAlD
Zonisamide—SCN1B—testis—hypothyroidism	0.00467	0.0097	CbGeAlD
Zonisamide—Affect lability—Dextrothyroxine—hypothyroidism	0.00466	0.0117	CcSEcCtD
Zonisamide—Affect lability—Levothyroxine—hypothyroidism	0.00466	0.0117	CcSEcCtD
Zonisamide—Tachycardia—Liothyronine—hypothyroidism	0.00462	0.0116	CcSEcCtD
Zonisamide—CA13—adrenal gland—hypothyroidism	0.00455	0.00944	CbGeAlD
Zonisamide—Blood urea increased—Liotrix—hypothyroidism	0.00453	0.0113	CcSEcCtD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00452	0.0381	CbGpPWpGaD
Zonisamide—Irritability—Dextrothyroxine—hypothyroidism	0.00452	0.0113	CcSEcCtD
Zonisamide—Irritability—Levothyroxine—hypothyroidism	0.00452	0.0113	CcSEcCtD
Zonisamide—Mood swings—Dextrothyroxine—hypothyroidism	0.00448	0.0112	CcSEcCtD
Zonisamide—Mood swings—Levothyroxine—hypothyroidism	0.00448	0.0112	CcSEcCtD
Zonisamide—CA10—testis—hypothyroidism	0.00448	0.0093	CbGeAlD
Zonisamide—SCN4B—adrenal gland—hypothyroidism	0.00444	0.00921	CbGeAlD
Zonisamide—Hypotension—Liothyronine—hypothyroidism	0.00443	0.0111	CcSEcCtD
Zonisamide—SCN1B—liver—hypothyroidism	0.00442	0.00917	CbGeAlD
Zonisamide—Dehydration—Levothyroxine—hypothyroidism	0.0044	0.011	CcSEcCtD
Zonisamide—Dehydration—Dextrothyroxine—hypothyroidism	0.0044	0.011	CcSEcCtD
Zonisamide—CA8—testis—hypothyroidism	0.0044	0.00912	CbGeAlD
Zonisamide—CA13—thyroid gland—hypothyroidism	0.00439	0.00911	CbGeAlD
Zonisamide—Coma—Liotrix—hypothyroidism	0.00438	0.011	CcSEcCtD
Zonisamide—SCN1B—cerebellum—hypothyroidism	0.00432	0.00896	CbGeAlD
Zonisamide—SCN3B—testis—hypothyroidism	0.00431	0.00895	CbGeAlD
Zonisamide—SCN4B—thyroid gland—hypothyroidism	0.00428	0.00888	CbGeAlD
Zonisamide—CA11—pituitary gland—hypothyroidism	0.00427	0.00887	CbGeAlD
Zonisamide—CA13—female gonad—hypothyroidism	0.00424	0.0088	CbGeAlD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.0042	0.0354	CbGpPWpGaD
Zonisamide—Hyperkinesia—Liotrix—hypothyroidism	0.00418	0.0105	CcSEcCtD
Zonisamide—Muscular weakness—Levothyroxine—hypothyroidism	0.00418	0.0105	CcSEcCtD
Zonisamide—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00418	0.0105	CcSEcCtD
Zonisamide—CA10—cerebellum—hypothyroidism	0.00414	0.00859	CbGeAlD
Zonisamide—Dysphagia—Levothyroxine—hypothyroidism	0.00409	0.0102	CcSEcCtD
Zonisamide—Dysphagia—Dextrothyroxine—hypothyroidism	0.00409	0.0102	CcSEcCtD
Zonisamide—CA8—cerebellum—hypothyroidism	0.00406	0.00842	CbGeAlD
Zonisamide—SCN3B—cerebellum—hypothyroidism	0.00398	0.00827	CbGeAlD
Zonisamide—MAOB—nerve—hypothyroidism	0.00383	0.00794	CbGeAlD
Zonisamide—CA11—adrenal gland—hypothyroidism	0.00382	0.00792	CbGeAlD
Zonisamide—CA11—blood—hypothyroidism	0.00382	0.00792	CbGeAlD
Zonisamide—CA13—testis—hypothyroidism	0.00376	0.00781	CbGeAlD
Zonisamide—Body temperature increased—Liothyronine—hypothyroidism	0.00375	0.00937	CcSEcCtD
Zonisamide—Weight decreased—Dextrothyroxine—hypothyroidism	0.0037	0.00927	CcSEcCtD
Zonisamide—Weight decreased—Levothyroxine—hypothyroidism	0.0037	0.00927	CcSEcCtD
Zonisamide—CA4—nerve—hypothyroidism	0.00369	0.00765	CbGeAlD
Zonisamide—CA11—thyroid gland—hypothyroidism	0.00368	0.00765	CbGeAlD
Zonisamide—SCN4B—testis—hypothyroidism	0.00367	0.00761	CbGeAlD
Zonisamide—CACNA1I—testis—hypothyroidism	0.00358	0.00744	CbGeAlD
Zonisamide—Cardiac failure—Liotrix—hypothyroidism	0.00357	0.00893	CcSEcCtD
Zonisamide—Hypoglycaemia—Liotrix—hypothyroidism	0.00357	0.00893	CcSEcCtD
Zonisamide—CA11—female gonad—hypothyroidism	0.00356	0.00739	CbGeAlD
Zonisamide—CA13—liver—hypothyroidism	0.00356	0.00738	CbGeAlD
Zonisamide—Cerebrovascular accident—Liotrix—hypothyroidism	0.00355	0.00889	CcSEcCtD
Zonisamide—Sweating—Levothyroxine—hypothyroidism	0.0035	0.00875	CcSEcCtD
Zonisamide—Sweating—Dextrothyroxine—hypothyroidism	0.0035	0.00875	CcSEcCtD
Zonisamide—CA13—cerebellum—hypothyroidism	0.00347	0.00721	CbGeAlD
Zonisamide—Affect lability—Liotrix—hypothyroidism	0.00343	0.00858	CcSEcCtD
Zonisamide—SCN4B—cerebellum—hypothyroidism	0.00339	0.00703	CbGeAlD
Zonisamide—Irritability—Liotrix—hypothyroidism	0.00332	0.00832	CcSEcCtD
Zonisamide—CACNA1I—cerebellum—hypothyroidism	0.00331	0.00687	CbGeAlD
Zonisamide—Mood swings—Liotrix—hypothyroidism	0.0033	0.00826	CcSEcCtD
Zonisamide—MAOA—nerve—hypothyroidism	0.00327	0.00678	CbGeAlD
Zonisamide—Blood creatinine increased—Liotrix—hypothyroidism	0.00326	0.00817	CcSEcCtD
Zonisamide—Dehydration—Liotrix—hypothyroidism	0.00324	0.00811	CcSEcCtD
Zonisamide—Hypokalaemia—Liotrix—hypothyroidism	0.00317	0.00793	CcSEcCtD
Zonisamide—CA11—testis—hypothyroidism	0.00316	0.00655	CbGeAlD
Zonisamide—CA3—heart—hypothyroidism	0.00312	0.00648	CbGeAlD
Zonisamide—Muscular weakness—Liotrix—hypothyroidism	0.00307	0.00769	CcSEcCtD
Zonisamide—Dysphagia—Liotrix—hypothyroidism	0.00301	0.00753	CcSEcCtD
Zonisamide—CA5A—liver—hypothyroidism	0.00299	0.0062	CbGeAlD
Zonisamide—CA3—cardiovascular system—hypothyroidism	0.00295	0.00611	CbGeAlD
Zonisamide—CA11—cerebellum—hypothyroidism	0.00292	0.00605	CbGeAlD
Zonisamide—Alopecia—Dextrothyroxine—hypothyroidism	0.00289	0.00724	CcSEcCtD
Zonisamide—Alopecia—Levothyroxine—hypothyroidism	0.00289	0.00724	CcSEcCtD
Zonisamide—CYP3A4—urine—hypothyroidism	0.00286	0.00593	CbGeAlD
Zonisamide—CA14—heart—hypothyroidism	0.00283	0.00588	CbGeAlD
Zonisamide—Tension—Dextrothyroxine—hypothyroidism	0.0028	0.007	CcSEcCtD
Zonisamide—Tension—Levothyroxine—hypothyroidism	0.0028	0.007	CcSEcCtD
Zonisamide—Nervousness—Levothyroxine—hypothyroidism	0.00277	0.00693	CcSEcCtD
Zonisamide—Nervousness—Dextrothyroxine—hypothyroidism	0.00277	0.00693	CcSEcCtD
Zonisamide—Weight decreased—Liotrix—hypothyroidism	0.00272	0.00682	CcSEcCtD
Zonisamide—Tremor—Dextrothyroxine—hypothyroidism	0.00267	0.00669	CcSEcCtD
Zonisamide—Tremor—Levothyroxine—hypothyroidism	0.00267	0.00669	CcSEcCtD
Zonisamide—Renal failure—Liotrix—hypothyroidism	0.00264	0.0066	CcSEcCtD
Zonisamide—Agitation—Dextrothyroxine—hypothyroidism	0.00262	0.00656	CcSEcCtD
Zonisamide—Agitation—Levothyroxine—hypothyroidism	0.00262	0.00656	CcSEcCtD
Zonisamide—CA3—pituitary gland—hypothyroidism	0.00261	0.00541	CbGeAlD
Zonisamide—CACNA1H—heart—hypothyroidism	0.0026	0.0054	CbGeAlD
Zonisamide—SCN5A—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.0026	0.0219	CbGpPWpGaD
Zonisamide—Sweating—Liotrix—hypothyroidism	0.00257	0.00644	CcSEcCtD
Zonisamide—MAOA—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00256	0.0216	CbGpPWpGaD
Zonisamide—Palpitations—Dextrothyroxine—hypothyroidism	0.00252	0.00631	CcSEcCtD
Zonisamide—Palpitations—Levothyroxine—hypothyroidism	0.00252	0.00631	CcSEcCtD
Zonisamide—SCN4A—heart—hypothyroidism	0.00248	0.00514	CbGeAlD
Zonisamide—Convulsion—Levothyroxine—hypothyroidism	0.00247	0.00618	CcSEcCtD
Zonisamide—Convulsion—Dextrothyroxine—hypothyroidism	0.00247	0.00618	CcSEcCtD
Zonisamide—CACNA1H—cardiovascular system—hypothyroidism	0.00246	0.0051	CbGeAlD
Zonisamide—Arthralgia—Dextrothyroxine—hypothyroidism	0.00243	0.00608	CcSEcCtD
Zonisamide—Arthralgia—Levothyroxine—hypothyroidism	0.00243	0.00608	CcSEcCtD
Zonisamide—Anxiety—Levothyroxine—hypothyroidism	0.00242	0.00605	CcSEcCtD
Zonisamide—Anxiety—Dextrothyroxine—hypothyroidism	0.00242	0.00605	CcSEcCtD
Zonisamide—SCN1B—Axon guidance—CLTC—hypothyroidism	0.00242	0.0204	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—CLTC—hypothyroidism	0.00242	0.0204	CbGpPWpGaD
Zonisamide—Confusional state—Levothyroxine—hypothyroidism	0.00235	0.00587	CcSEcCtD
Zonisamide—Confusional state—Dextrothyroxine—hypothyroidism	0.00235	0.00587	CcSEcCtD
Zonisamide—SCN9A—pituitary gland—hypothyroidism	0.00232	0.00482	CbGeAlD
Zonisamide—Shock—Dextrothyroxine—hypothyroidism	0.00229	0.00573	CcSEcCtD
Zonisamide—Shock—Levothyroxine—hypothyroidism	0.00229	0.00573	CcSEcCtD
Zonisamide—Tachycardia—Levothyroxine—hypothyroidism	0.00227	0.00568	CcSEcCtD
Zonisamide—Tachycardia—Dextrothyroxine—hypothyroidism	0.00227	0.00568	CcSEcCtD
Zonisamide—CACNA1G—cerebellum—hypothyroidism	0.00227	0.00471	CbGeAlD
Zonisamide—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00225	0.00563	CcSEcCtD
Zonisamide—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00225	0.00563	CcSEcCtD
Zonisamide—CA3—thyroid gland—hypothyroidism	0.00225	0.00467	CbGeAlD
Zonisamide—CACNA1H—gonad—hypothyroidism	0.00223	0.00463	CbGeAlD
Zonisamide—SCN4B—Axon guidance—CLTC—hypothyroidism	0.00221	0.0186	CbGpPWpGaD
Zonisamide—CACNA1H—pituitary gland—hypothyroidism	0.00217	0.00451	CbGeAlD
Zonisamide—Alopecia—Liotrix—hypothyroidism	0.00213	0.00533	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00212	0.00531	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00212	0.00531	CcSEcCtD
Zonisamide—CA14—adrenal gland—hypothyroidism	0.00212	0.00439	CbGeAlD
Zonisamide—Insomnia—Dextrothyroxine—hypothyroidism	0.0021	0.00527	CcSEcCtD
Zonisamide—Insomnia—Levothyroxine—hypothyroidism	0.0021	0.00527	CcSEcCtD
Zonisamide—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00207	0.00519	CcSEcCtD
Zonisamide—Dyspnoea—Levothyroxine—hypothyroidism	0.00207	0.00519	CcSEcCtD
Zonisamide—SCN9A—adrenal gland—hypothyroidism	0.00207	0.0043	CbGeAlD
Zonisamide—SCN4A—pituitary gland—hypothyroidism	0.00207	0.0043	CbGeAlD
Zonisamide—Flatulence—Liotrix—hypothyroidism	0.00207	0.00517	CcSEcCtD
Zonisamide—Tension—Liotrix—hypothyroidism	0.00206	0.00515	CcSEcCtD
Zonisamide—SCN3B—Axon guidance—CLTC—hypothyroidism	0.00205	0.0173	CbGpPWpGaD
Zonisamide—Dysgeusia—Liotrix—hypothyroidism	0.00205	0.00514	CcSEcCtD
Zonisamide—Nervousness—Liotrix—hypothyroidism	0.00204	0.0051	CcSEcCtD
Zonisamide—Fatigue—Levothyroxine—hypothyroidism	0.00201	0.00502	CcSEcCtD
Zonisamide—Fatigue—Dextrothyroxine—hypothyroidism	0.00201	0.00502	CcSEcCtD
Zonisamide—CA5B—heart—hypothyroidism	0.00198	0.00412	CbGeAlD
Zonisamide—Tremor—Liotrix—hypothyroidism	0.00196	0.00492	CcSEcCtD
Zonisamide—CACNA1H—adrenal gland—hypothyroidism	0.00194	0.00403	CbGeAlD
Zonisamide—CA7—cerebellum—hypothyroidism	0.00194	0.00403	CbGeAlD
Zonisamide—SCN3A—heart—hypothyroidism	0.00193	0.004	CbGeAlD
Zonisamide—Agitation—Liotrix—hypothyroidism	0.00193	0.00482	CcSEcCtD
Zonisamide—CA3—testis—hypothyroidism	0.00193	0.004	CbGeAlD
Zonisamide—SCN5A—heart—hypothyroidism	0.00192	0.00399	CbGeAlD
Zonisamide—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00192	0.0048	CcSEcCtD
Zonisamide—Feeling abnormal—Levothyroxine—hypothyroidism	0.00192	0.0048	CcSEcCtD
Zonisamide—AOX1—adrenal cortex—hypothyroidism	0.00191	0.00396	CbGeAlD
Zonisamide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.0019	0.00476	CcSEcCtD
Zonisamide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.0019	0.00476	CcSEcCtD
Zonisamide—CA13—Metabolism—IYD—hypothyroidism	0.00188	0.0159	CbGpPWpGaD
Zonisamide—Syncope—Liotrix—hypothyroidism	0.00188	0.00471	CcSEcCtD
Zonisamide—CACNA1H—thyroid gland—hypothyroidism	0.00187	0.00389	CbGeAlD
Zonisamide—CA5B—cardiovascular system—hypothyroidism	0.00187	0.00388	CbGeAlD
Zonisamide—Palpitations—Liotrix—hypothyroidism	0.00185	0.00464	CcSEcCtD
Zonisamide—SCN4A—adrenal gland—hypothyroidism	0.00185	0.00384	CbGeAlD
Zonisamide—Urticaria—Levothyroxine—hypothyroidism	0.00185	0.00463	CcSEcCtD
Zonisamide—Urticaria—Dextrothyroxine—hypothyroidism	0.00185	0.00463	CcSEcCtD
Zonisamide—CA9—testis—hypothyroidism	0.00184	0.00383	CbGeAlD
Zonisamide—AOX1—heart—hypothyroidism	0.00184	0.00383	CbGeAlD
Zonisamide—Loss of consciousness—Liotrix—hypothyroidism	0.00184	0.00461	CcSEcCtD
Zonisamide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00184	0.0046	CcSEcCtD
Zonisamide—Body temperature increased—Levothyroxine—hypothyroidism	0.00184	0.0046	CcSEcCtD
Zonisamide—Abdominal pain—Levothyroxine—hypothyroidism	0.00184	0.0046	CcSEcCtD
Zonisamide—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00184	0.0046	CcSEcCtD
Zonisamide—SCN2A—pituitary gland—hypothyroidism	0.00183	0.0038	CbGeAlD
Zonisamide—CA3—liver—hypothyroidism	0.00182	0.00378	CbGeAlD
Zonisamide—Convulsion—Liotrix—hypothyroidism	0.00182	0.00455	CcSEcCtD
Zonisamide—SCN5A—cardiovascular system—hypothyroidism	0.00181	0.00376	CbGeAlD
Zonisamide—CACNA1H—female gonad—hypothyroidism	0.00181	0.00376	CbGeAlD
Zonisamide—Hypertension—Liotrix—hypothyroidism	0.00181	0.00453	CcSEcCtD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.0018	0.0152	CbGpPWpGaD
Zonisamide—Arthralgia—Liotrix—hypothyroidism	0.00179	0.00447	CcSEcCtD
Zonisamide—Chest pain—Liotrix—hypothyroidism	0.00179	0.00447	CcSEcCtD
Zonisamide—SCN4A—thyroid gland—hypothyroidism	0.00178	0.0037	CbGeAlD
Zonisamide—Anxiety—Liotrix—hypothyroidism	0.00178	0.00445	CcSEcCtD
Zonisamide—CA1—heart—hypothyroidism	0.00175	0.00363	CbGeAlD
Zonisamide—Confusional state—Liotrix—hypothyroidism	0.00173	0.00432	CcSEcCtD
Zonisamide—SCN1B—Developmental Biology—CLTC—hypothyroidism	0.00172	0.0145	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—CLTC—hypothyroidism	0.00172	0.0145	CbGpPWpGaD
Zonisamide—SCN9A—testis—hypothyroidism	0.00171	0.00356	CbGeAlD
Zonisamide—Oedema—Liotrix—hypothyroidism	0.00171	0.00428	CcSEcCtD
Zonisamide—CA9—cerebellum—hypothyroidism	0.0017	0.00354	CbGeAlD
Zonisamide—Infection—Liotrix—hypothyroidism	0.0017	0.00426	CcSEcCtD
Zonisamide—CA5B—gonad—hypothyroidism	0.0017	0.00352	CbGeAlD
Zonisamide—Shock—Liotrix—hypothyroidism	0.00168	0.00421	CcSEcCtD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00167	0.0141	CbGpPWpGaD
Zonisamide—Tachycardia—Liotrix—hypothyroidism	0.00167	0.00418	CcSEcCtD
Zonisamide—Asthenia—Dextrothyroxine—hypothyroidism	0.00167	0.00418	CcSEcCtD
Zonisamide—Asthenia—Levothyroxine—hypothyroidism	0.00167	0.00418	CcSEcCtD
Zonisamide—Hyperhidrosis—Liotrix—hypothyroidism	0.00165	0.00414	CcSEcCtD
Zonisamide—CA14—liver—hypothyroidism	0.00165	0.00343	CbGeAlD
Zonisamide—CA1—cardiovascular system—hypothyroidism	0.00165	0.00343	CbGeAlD
Zonisamide—Pruritus—Dextrothyroxine—hypothyroidism	0.00165	0.00412	CcSEcCtD
Zonisamide—Pruritus—Levothyroxine—hypothyroidism	0.00165	0.00412	CcSEcCtD
Zonisamide—SCN2A—blood—hypothyroidism	0.00164	0.0034	CbGeAlD
Zonisamide—Anorexia—Liotrix—hypothyroidism	0.00163	0.00408	CcSEcCtD
Zonisamide—CA14—cerebellum—hypothyroidism	0.00162	0.00335	CbGeAlD
Zonisamide—SCN3A—pituitary gland—hypothyroidism	0.00161	0.00334	CbGeAlD
Zonisamide—CACNA1H—testis—hypothyroidism	0.00161	0.00333	CbGeAlD
Zonisamide—CA13—Metabolism—ATP5O—hypothyroidism	0.0016	0.0135	CbGpPWpGaD
Zonisamide—Hypotension—Liotrix—hypothyroidism	0.0016	0.004	CcSEcCtD
Zonisamide—Diarrhoea—Levothyroxine—hypothyroidism	0.00159	0.00398	CcSEcCtD
Zonisamide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00159	0.00398	CcSEcCtD
Zonisamide—AOX1—gonad—hypothyroidism	0.00158	0.00328	CbGeAlD
Zonisamide—SCN4B—Developmental Biology—CLTC—hypothyroidism	0.00158	0.0133	CbGpPWpGaD
Zonisamide—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00156	0.0039	CcSEcCtD
Zonisamide—Insomnia—Liotrix—hypothyroidism	0.00155	0.00387	CcSEcCtD
Zonisamide—AOX1—pituitary gland—hypothyroidism	0.00154	0.0032	CbGeAlD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00154	0.013	CbGpPWpGaD
Zonisamide—Paraesthesia—Liotrix—hypothyroidism	0.00154	0.00385	CcSEcCtD
Zonisamide—SCN4A—testis—hypothyroidism	0.00153	0.00317	CbGeAlD
Zonisamide—Dyspnoea—Liotrix—hypothyroidism	0.00153	0.00382	CcSEcCtD
Zonisamide—CACNA1H—liver—hypothyroidism	0.00152	0.00315	CbGeAlD
Zonisamide—CA13—Metabolism—TPO—hypothyroidism	0.00151	0.0127	CbGpPWpGaD
Zonisamide—Decreased appetite—Liotrix—hypothyroidism	0.00149	0.00372	CcSEcCtD
Zonisamide—CACNA1H—cerebellum—hypothyroidism	0.00148	0.00308	CbGeAlD
Zonisamide—CA5B—adrenal gland—hypothyroidism	0.00148	0.00307	CbGeAlD
Zonisamide—CA5B—blood—hypothyroidism	0.00148	0.00307	CbGeAlD
Zonisamide—Vomiting—Dextrothyroxine—hypothyroidism	0.00148	0.0037	CcSEcCtD
Zonisamide—Vomiting—Levothyroxine—hypothyroidism	0.00148	0.0037	CcSEcCtD
Zonisamide—Fatigue—Liotrix—hypothyroidism	0.00148	0.00369	CcSEcCtD
Zonisamide—MAOB—adrenal cortex—hypothyroidism	0.00147	0.00305	CbGeAlD
Zonisamide—Rash—Dextrothyroxine—hypothyroidism	0.00147	0.00367	CcSEcCtD
Zonisamide—Rash—Levothyroxine—hypothyroidism	0.00147	0.00367	CcSEcCtD
Zonisamide—Dermatitis—Dextrothyroxine—hypothyroidism	0.00147	0.00367	CcSEcCtD
Zonisamide—Dermatitis—Levothyroxine—hypothyroidism	0.00147	0.00367	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—CLTC—hypothyroidism	0.00147	0.0124	CbGpPWpGaD
Zonisamide—Constipation—Liotrix—hypothyroidism	0.00146	0.00366	CcSEcCtD
Zonisamide—Headache—Levothyroxine—hypothyroidism	0.00146	0.00365	CcSEcCtD
Zonisamide—Headache—Dextrothyroxine—hypothyroidism	0.00146	0.00365	CcSEcCtD
Zonisamide—SCN3A—adrenal gland—hypothyroidism	0.00144	0.00299	CbGeAlD
Zonisamide—SCN3A—blood—hypothyroidism	0.00144	0.00298	CbGeAlD
Zonisamide—SCN5A—blood—hypothyroidism	0.00143	0.00298	CbGeAlD
Zonisamide—CA5B—thyroid gland—hypothyroidism	0.00143	0.00296	CbGeAlD
Zonisamide—MAOB—heart—hypothyroidism	0.00142	0.00295	CbGeAlD
Zonisamide—Feeling abnormal—Liotrix—hypothyroidism	0.00141	0.00353	CcSEcCtD
Zonisamide—Gastrointestinal pain—Liotrix—hypothyroidism	0.0014	0.0035	CcSEcCtD
Zonisamide—SCN3A—thyroid gland—hypothyroidism	0.00139	0.00288	CbGeAlD
Zonisamide—Nausea—Dextrothyroxine—hypothyroidism	0.00138	0.00346	CcSEcCtD
Zonisamide—Nausea—Levothyroxine—hypothyroidism	0.00138	0.00346	CcSEcCtD
Zonisamide—AOX1—adrenal gland—hypothyroidism	0.00138	0.00286	CbGeAlD
Zonisamide—CA4—heart—hypothyroidism	0.00137	0.00284	CbGeAlD
Zonisamide—SCN1A—cerebellum—hypothyroidism	0.00136	0.00283	CbGeAlD
Zonisamide—Urticaria—Liotrix—hypothyroidism	0.00136	0.0034	CcSEcCtD
Zonisamide—Body temperature increased—Liotrix—hypothyroidism	0.00135	0.00339	CcSEcCtD
Zonisamide—Abdominal pain—Liotrix—hypothyroidism	0.00135	0.00339	CcSEcCtD
Zonisamide—MAOB—cardiovascular system—hypothyroidism	0.00134	0.00278	CbGeAlD
Zonisamide—AOX1—thyroid gland—hypothyroidism	0.00133	0.00276	CbGeAlD
Zonisamide—CA1—blood—hypothyroidism	0.00131	0.00271	CbGeAlD
Zonisamide—CA4—cardiovascular system—hypothyroidism	0.00129	0.00268	CbGeAlD
Zonisamide—AOX1—female gonad—hypothyroidism	0.00128	0.00266	CbGeAlD
Zonisamide—Hypersensitivity—Liotrix—hypothyroidism	0.00126	0.00316	CcSEcCtD
Zonisamide—MAOA—adrenal cortex—hypothyroidism	0.00125	0.0026	CbGeAlD
Zonisamide—SCN2A—cerebellum—hypothyroidism	0.00125	0.00259	CbGeAlD
Zonisamide—Asthenia—Liotrix—hypothyroidism	0.00123	0.00307	CcSEcCtD
Zonisamide—CA5B—testis—hypothyroidism	0.00122	0.00254	CbGeAlD
Zonisamide—MAOA—heart—hypothyroidism	0.00121	0.00252	CbGeAlD
Zonisamide—Pruritus—Liotrix—hypothyroidism	0.00121	0.00303	CcSEcCtD
Zonisamide—SCN3A—testis—hypothyroidism	0.00119	0.00247	CbGeAlD
Zonisamide—MAOB—pituitary gland—hypothyroidism	0.00119	0.00246	CbGeAlD
Zonisamide—CA2—adrenal cortex—hypothyroidism	0.00117	0.00244	CbGeAlD
Zonisamide—Diarrhoea—Liotrix—hypothyroidism	0.00117	0.00293	CcSEcCtD
Zonisamide—MAOA—cardiovascular system—hypothyroidism	0.00114	0.00237	CbGeAlD
Zonisamide—CA4—pituitary gland—hypothyroidism	0.00114	0.00237	CbGeAlD
Zonisamide—AOX1—testis—hypothyroidism	0.00114	0.00236	CbGeAlD
Zonisamide—SCN1B—Axon guidance—VAV3—hypothyroidism	0.00114	0.00959	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—VAV3—hypothyroidism	0.00114	0.00959	CbGpPWpGaD
Zonisamide—CA2—heart—hypothyroidism	0.00114	0.00236	CbGeAlD
Zonisamide—Dizziness—Liotrix—hypothyroidism	0.00113	0.00283	CcSEcCtD
Zonisamide—CACNA1I—Axon guidance—CLTC—hypothyroidism	0.00111	0.00935	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.0011	0.00928	CbGpPWpGaD
Zonisamide—SCN3A—cerebellum—hypothyroidism	0.0011	0.00228	CbGeAlD
Zonisamide—Vomiting—Liotrix—hypothyroidism	0.00109	0.00272	CcSEcCtD
Zonisamide—Rash—Liotrix—hypothyroidism	0.00108	0.0027	CcSEcCtD
Zonisamide—Dermatitis—Liotrix—hypothyroidism	0.00108	0.0027	CcSEcCtD
Zonisamide—AOX1—liver—hypothyroidism	0.00108	0.00223	CbGeAlD
Zonisamide—Headache—Liotrix—hypothyroidism	0.00107	0.00268	CcSEcCtD
Zonisamide—CA2—cardiovascular system—hypothyroidism	0.00107	0.00222	CbGeAlD
Zonisamide—MAOB—adrenal gland—hypothyroidism	0.00106	0.0022	CbGeAlD
Zonisamide—MAOB—blood—hypothyroidism	0.00106	0.0022	CbGeAlD
Zonisamide—AOX1—cerebellum—hypothyroidism	0.00105	0.00218	CbGeAlD
Zonisamide—SCN11A—Axon guidance—CLTC—hypothyroidism	0.00105	0.00886	CbGpPWpGaD
Zonisamide—SCN4B—Axon guidance—VAV3—hypothyroidism	0.00104	0.00877	CbGpPWpGaD
Zonisamide—MAOB—thyroid gland—hypothyroidism	0.00102	0.00212	CbGeAlD
Zonisamide—CA1—liver—hypothyroidism	0.00102	0.00212	CbGeAlD
Zonisamide—CA4—adrenal gland—hypothyroidism	0.00102	0.00212	CbGeAlD
Zonisamide—CA4—blood—hypothyroidism	0.00102	0.00212	CbGeAlD
Zonisamide—Nausea—Liotrix—hypothyroidism	0.00102	0.00254	CcSEcCtD
Zonisamide—MAOA—pituitary gland—hypothyroidism	0.00101	0.0021	CbGeAlD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000991	0.00836	CbGpPWpGaD
Zonisamide—MAOB—female gonad—hypothyroidism	0.000989	0.00205	CbGeAlD
Zonisamide—CA3—Metabolism—IYD—hypothyroidism	0.000989	0.00834	CbGpPWpGaD
Zonisamide—CA4—thyroid gland—hypothyroidism	0.000986	0.00205	CbGeAlD
Zonisamide—SCN3B—Axon guidance—VAV3—hypothyroidism	0.000968	0.00816	CbGpPWpGaD
Zonisamide—CA4—female gonad—hypothyroidism	0.000953	0.00198	CbGeAlD
Zonisamide—CA2—pituitary gland—hypothyroidism	0.000948	0.00197	CbGeAlD
Zonisamide—CYP2C19—blood—hypothyroidism	0.000924	0.00192	CbGeAlD
Zonisamide—MAOA—adrenal gland—hypothyroidism	0.000905	0.00188	CbGeAlD
Zonisamide—MAOA—blood—hypothyroidism	0.000905	0.00188	CbGeAlD
Zonisamide—MAOB—testis—hypothyroidism	0.000877	0.00182	CbGeAlD
Zonisamide—MAOA—thyroid gland—hypothyroidism	0.000873	0.00181	CbGeAlD
Zonisamide—CA2—adrenal gland—hypothyroidism	0.000847	0.00176	CbGeAlD
Zonisamide—CA2—blood—hypothyroidism	0.000847	0.00176	CbGeAlD
Zonisamide—CA4—testis—hypothyroidism	0.000845	0.00175	CbGeAlD
Zonisamide—MAOA—female gonad—hypothyroidism	0.000844	0.00175	CbGeAlD
Zonisamide—CA3—Metabolism—ATP5O—hypothyroidism	0.000841	0.00709	CbGpPWpGaD
Zonisamide—MAOB—liver—hypothyroidism	0.000829	0.00172	CbGeAlD
Zonisamide—CACNA1G—Axon guidance—CLTC—hypothyroidism	0.000818	0.00689	CbGpPWpGaD
Zonisamide—CA2—thyroid gland—hypothyroidism	0.000818	0.0017	CbGeAlD
Zonisamide—SCN2B—Developmental Biology—VAV3—hypothyroidism	0.000812	0.00685	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—VAV3—hypothyroidism	0.000812	0.00685	CbGpPWpGaD
Zonisamide—MAOB—cerebellum—hypothyroidism	0.00081	0.00168	CbGeAlD
Zonisamide—CACNA1H—Axon guidance—CLTC—hypothyroidism	0.000792	0.00667	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—CLTC—hypothyroidism	0.000791	0.00667	CbGpPWpGaD
Zonisamide—CA3—Metabolism—TPO—hypothyroidism	0.000791	0.00666	CbGpPWpGaD
Zonisamide—CA2—female gonad—hypothyroidism	0.00079	0.00164	CbGeAlD
Zonisamide—CA4—cerebellum—hypothyroidism	0.00078	0.00162	CbGeAlD
Zonisamide—SCN9A—Axon guidance—CLTC—hypothyroidism	0.000778	0.00655	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—CLTC—hypothyroidism	0.00075	0.00632	CbGpPWpGaD
Zonisamide—MAOA—testis—hypothyroidism	0.000748	0.00155	CbGeAlD
Zonisamide—SCN3A—Axon guidance—CLTC—hypothyroidism	0.000744	0.00627	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—VAV3—hypothyroidism	0.000743	0.00626	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000735	0.0062	CbGpPWpGaD
Zonisamide—CYP2C19—liver—hypothyroidism	0.000723	0.0015	CbGeAlD
Zonisamide—SCN2A—Axon guidance—CLTC—hypothyroidism	0.000715	0.00602	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—CLTC—hypothyroidism	0.000715	0.00602	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000709	0.00598	CbGpPWpGaD
Zonisamide—MAOA—liver—hypothyroidism	0.000708	0.00147	CbGeAlD
Zonisamide—CA2—testis—hypothyroidism	0.000701	0.00145	CbGeAlD
Zonisamide—CA13—Metabolism—TSHB—hypothyroidism	0.000697	0.00587	CbGpPWpGaD
Zonisamide—MAOA—cerebellum—hypothyroidism	0.000691	0.00143	CbGeAlD
Zonisamide—SCN3B—Developmental Biology—VAV3—hypothyroidism	0.000691	0.00582	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—CLTC—hypothyroidism	0.000689	0.00581	CbGpPWpGaD
Zonisamide—CA2—liver—hypothyroidism	0.000662	0.00137	CbGeAlD
Zonisamide—CACNA1H—Corticotropin-releasing hormone—POMC—hypothyroidism	0.000654	0.00551	CbGpPWpGaD
Zonisamide—CA2—cerebellum—hypothyroidism	0.000647	0.00134	CbGeAlD
Zonisamide—CA14—Metabolism—IYD—hypothyroidism	0.000637	0.00537	CbGpPWpGaD
Zonisamide—CA13—Metabolism—PIK3C2A—hypothyroidism	0.000621	0.00523	CbGpPWpGaD
Zonisamide—CA6—Metabolism—IYD—hypothyroidism	0.000621	0.00523	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—IYD—hypothyroidism	0.000621	0.00523	CbGpPWpGaD
Zonisamide—SCN5A—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.000598	0.00504	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—CLTC—hypothyroidism	0.000583	0.00492	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—IYD—hypothyroidism	0.00058	0.00489	CbGpPWpGaD
Zonisamide—CA7—Metabolism—IYD—hypothyroidism	0.00058	0.00489	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—CLTC—hypothyroidism	0.000565	0.00476	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—SLC5A7—hypothyroidism	0.000563	0.00475	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—CLTC—hypothyroidism	0.000555	0.00468	CbGpPWpGaD
Zonisamide—CYP3A4—blood—hypothyroidism	0.000546	0.00113	CbGeAlD
Zonisamide—CA14—Metabolism—ATP5O—hypothyroidism	0.000542	0.00457	CbGpPWpGaD
Zonisamide—CA12—Metabolism—IYD—hypothyroidism	0.000537	0.00453	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—CLTC—hypothyroidism	0.000531	0.00447	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ATP5O—hypothyroidism	0.000528	0.00445	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—ATP5O—hypothyroidism	0.000528	0.00445	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—VAV3—hypothyroidism	0.000523	0.0044	CbGpPWpGaD
Zonisamide—CA13—Metabolism—SLC5A5—hypothyroidism	0.000522	0.0044	CbGpPWpGaD
Zonisamide—MAOB—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000521	0.00439	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—CLTC—hypothyroidism	0.00051	0.0043	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—CLTC—hypothyroidism	0.00051	0.0043	CbGpPWpGaD
Zonisamide—CA14—Metabolism—TPO—hypothyroidism	0.00051	0.00429	CbGpPWpGaD
Zonisamide—CA6—Metabolism—TPO—hypothyroidism	0.000497	0.00418	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—TPO—hypothyroidism	0.000497	0.00418	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—VAV3—hypothyroidism	0.000495	0.00418	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ATP5O—hypothyroidism	0.000493	0.00416	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ATP5O—hypothyroidism	0.000493	0.00416	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—CLTC—hypothyroidism	0.000492	0.00414	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—CLTC—hypothyroidism	0.000484	0.00408	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000474	0.00399	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—TPO—hypothyroidism	0.000464	0.00391	CbGpPWpGaD
Zonisamide—CA7—Metabolism—TPO—hypothyroidism	0.000464	0.00391	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ATP5O—hypothyroidism	0.000457	0.00385	CbGpPWpGaD
Zonisamide—CA12—Metabolism—TPO—hypothyroidism	0.000429	0.00362	CbGpPWpGaD
Zonisamide—CA4—Metabolism—IYD—hypothyroidism	0.000428	0.00361	CbGpPWpGaD
Zonisamide—CYP3A4—liver—hypothyroidism	0.000427	0.000887	CbGeAlD
Zonisamide—CA2—Metabolism—IYD—hypothyroidism	0.000411	0.00346	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000395	0.00333	CbGpPWpGaD
Zonisamide—CA1—Metabolism—IYD—hypothyroidism	0.000394	0.00332	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—IYD—hypothyroidism	0.000386	0.00325	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—VAV3—hypothyroidism	0.000385	0.00325	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—VAV3—hypothyroidism	0.000373	0.00314	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—VAV3—hypothyroidism	0.000373	0.00314	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—VAV3—hypothyroidism	0.000366	0.00309	CbGpPWpGaD
Zonisamide—CA3—Metabolism—TSHB—hypothyroidism	0.000366	0.00308	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ATP5O—hypothyroidism	0.000364	0.00307	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—NEFL—hypothyroidism	0.000363	0.00306	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—VAV3—hypothyroidism	0.000354	0.00298	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—VAV3—hypothyroidism	0.000351	0.00295	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ATP5O—hypothyroidism	0.000349	0.00294	CbGpPWpGaD
Zonisamide—CA9—Metabolism—IYD—hypothyroidism	0.000346	0.00292	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CLTC—hypothyroidism	0.000346	0.00291	CbGpPWpGaD
Zonisamide—CA4—Metabolism—TPO—hypothyroidism	0.000342	0.00289	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—VAV3—hypothyroidism	0.000337	0.00284	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—VAV3—hypothyroidism	0.000337	0.00284	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ATP5O—hypothyroidism	0.000335	0.00282	CbGpPWpGaD
Zonisamide—CA2—Metabolism—TPO—hypothyroidism	0.000328	0.00277	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ATP5O—hypothyroidism	0.000328	0.00277	CbGpPWpGaD
Zonisamide—MAOA—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000327	0.00275	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—IYD—hypothyroidism	0.000326	0.00275	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PIK3C2A—hypothyroidism	0.000326	0.00275	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—VAV3—hypothyroidism	0.000325	0.00274	CbGpPWpGaD
Zonisamide—CA1—Metabolism—TPO—hypothyroidism	0.000315	0.00265	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—TPO—hypothyroidism	0.000309	0.0026	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ATP5O—hypothyroidism	0.000294	0.00248	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000282	0.00238	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ATP5O—hypothyroidism	0.000277	0.00234	CbGpPWpGaD
Zonisamide—CA9—Metabolism—TPO—hypothyroidism	0.000277	0.00233	CbGpPWpGaD
Zonisamide—MAOB—Biological oxidations—POMC—hypothyroidism	0.000277	0.00233	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—VAV3—hypothyroidism	0.000275	0.00232	CbGpPWpGaD
Zonisamide—CA3—Metabolism—SLC5A5—hypothyroidism	0.000274	0.00231	CbGpPWpGaD
Zonisamide—CA13—Metabolism—POMC—hypothyroidism	0.000273	0.0023	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—VAV3—hypothyroidism	0.000266	0.00224	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—VAV3—hypothyroidism	0.000262	0.0022	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—TPO—hypothyroidism	0.000261	0.0022	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VAV3—hypothyroidism	0.00025	0.00211	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VAV3—hypothyroidism	0.00024	0.00203	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VAV3—hypothyroidism	0.00024	0.00203	CbGpPWpGaD
Zonisamide—CA14—Metabolism—TSHB—hypothyroidism	0.000236	0.00199	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VAV3—hypothyroidism	0.000232	0.00195	CbGpPWpGaD
Zonisamide—CA6—Metabolism—TSHB—hypothyroidism	0.00023	0.00194	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—TSHB—hypothyroidism	0.00023	0.00194	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VAV3—hypothyroidism	0.000228	0.00192	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—TSHB—hypothyroidism	0.000215	0.00181	CbGpPWpGaD
Zonisamide—CA7—Metabolism—TSHB—hypothyroidism	0.000215	0.00181	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3C2A—hypothyroidism	0.00021	0.00177	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3C2A—hypothyroidism	0.000205	0.00173	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3C2A—hypothyroidism	0.000205	0.00173	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—IYD—hypothyroidism	0.000205	0.00173	CbGpPWpGaD
Zonisamide—CA12—Metabolism—TSHB—hypothyroidism	0.000199	0.00168	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3C2A—hypothyroidism	0.000191	0.00161	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3C2A—hypothyroidism	0.000191	0.00161	CbGpPWpGaD
Zonisamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000191	0.00161	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3C2A—hypothyroidism	0.000177	0.00149	CbGpPWpGaD
Zonisamide—CA14—Metabolism—SLC5A5—hypothyroidism	0.000177	0.00149	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ATP5O—hypothyroidism	0.000174	0.00147	CbGpPWpGaD
Zonisamide—MAOA—Biological oxidations—POMC—hypothyroidism	0.000174	0.00146	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—SLC5A5—hypothyroidism	0.000172	0.00145	CbGpPWpGaD
Zonisamide—CA6—Metabolism—SLC5A5—hypothyroidism	0.000172	0.00145	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TPO—hypothyroidism	0.000164	0.00138	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VAV3—hypothyroidism	0.000163	0.00137	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—SLC5A5—hypothyroidism	0.000161	0.00135	CbGpPWpGaD
Zonisamide—CA7—Metabolism—SLC5A5—hypothyroidism	0.000161	0.00135	CbGpPWpGaD
Zonisamide—CA4—Metabolism—TSHB—hypothyroidism	0.000159	0.00134	CbGpPWpGaD
Zonisamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000155	0.0013	CbGpPWpGaD
Zonisamide—CA2—Metabolism—TSHB—hypothyroidism	0.000152	0.00128	CbGpPWpGaD
Zonisamide—CA12—Metabolism—SLC5A5—hypothyroidism	0.000149	0.00125	CbGpPWpGaD
Zonisamide—CA1—Metabolism—TSHB—hypothyroidism	0.000146	0.00123	CbGpPWpGaD
Zonisamide—CA3—Metabolism—POMC—hypothyroidism	0.000143	0.00121	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—TSHB—hypothyroidism	0.000143	0.0012	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3C2A—hypothyroidism	0.000141	0.00119	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3C2A—hypothyroidism	0.000135	0.00114	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3C2A—hypothyroidism	0.00013	0.00109	CbGpPWpGaD
Zonisamide—CA9—Metabolism—TSHB—hypothyroidism	0.000128	0.00108	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3C2A—hypothyroidism	0.000127	0.00107	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—TSHB—hypothyroidism	0.000121	0.00102	CbGpPWpGaD
Zonisamide—CA4—Metabolism—SLC5A5—hypothyroidism	0.000119	0.001	CbGpPWpGaD
Zonisamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000115	0.000967	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3C2A—hypothyroidism	0.000114	0.000962	CbGpPWpGaD
Zonisamide—CA2—Metabolism—SLC5A5—hypothyroidism	0.000114	0.000959	CbGpPWpGaD
Zonisamide—AOX1—Disease—PRL—hypothyroidism	0.000113	0.000951	CbGpPWpGaD
Zonisamide—CA1—Metabolism—SLC5A5—hypothyroidism	0.000109	0.000919	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3C2A—hypothyroidism	0.000108	0.000907	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—SLC5A5—hypothyroidism	0.000107	0.000902	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—IYD—hypothyroidism	9.69e-05	0.000817	CbGpPWpGaD
Zonisamide—CA9—Metabolism—SLC5A5—hypothyroidism	9.59e-05	0.000808	CbGpPWpGaD
Zonisamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	9.3e-05	0.000784	CbGpPWpGaD
Zonisamide—CA14—Metabolism—POMC—hypothyroidism	9.24e-05	0.000779	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SLC5A5—hypothyroidism	9.04e-05	0.000762	CbGpPWpGaD
Zonisamide—CA6—Metabolism—POMC—hypothyroidism	9e-05	0.000759	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—POMC—hypothyroidism	9e-05	0.000759	CbGpPWpGaD
Zonisamide—CA7—Metabolism—POMC—hypothyroidism	8.4e-05	0.000708	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—POMC—hypothyroidism	8.4e-05	0.000708	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ATP5O—hypothyroidism	8.24e-05	0.000694	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—POMC—hypothyroidism	8.21e-05	0.000692	CbGpPWpGaD
Zonisamide—CA12—Metabolism—POMC—hypothyroidism	7.79e-05	0.000656	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TPO—hypothyroidism	7.75e-05	0.000653	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TSHB—hypothyroidism	7.58e-05	0.000639	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.18e-05	0.000605	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3C2A—hypothyroidism	6.75e-05	0.000569	CbGpPWpGaD
Zonisamide—CA4—Metabolism—POMC—hypothyroidism	6.21e-05	0.000523	CbGpPWpGaD
Zonisamide—CA2—Metabolism—POMC—hypothyroidism	5.95e-05	0.000502	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—IYD—hypothyroidism	5.83e-05	0.000491	CbGpPWpGaD
Zonisamide—CA1—Metabolism—POMC—hypothyroidism	5.71e-05	0.000481	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC5A5—hypothyroidism	5.67e-05	0.000478	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—POMC—hypothyroidism	5.6e-05	0.000472	CbGpPWpGaD
Zonisamide—CA9—Metabolism—POMC—hypothyroidism	5.02e-05	0.000423	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ATP5O—hypothyroidism	4.95e-05	0.000418	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—POMC—hypothyroidism	4.94e-05	0.000416	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—POMC—hypothyroidism	4.73e-05	0.000399	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TPO—hypothyroidism	4.66e-05	0.000393	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TSHB—hypothyroidism	3.59e-05	0.000302	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	3.2e-05	0.000269	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.15e-05	0.000266	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—POMC—hypothyroidism	2.97e-05	0.00025	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC5A5—hypothyroidism	2.68e-05	0.000226	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TSHB—hypothyroidism	2.16e-05	0.000182	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.92e-05	0.000162	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.61e-05	0.000136	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—POMC—hypothyroidism	1.4e-05	0.000118	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—POMC—hypothyroidism	8.45e-06	7.12e-05	CbGpPWpGaD
